Adverum Biotechnologies, Inc.

CIK 1501756 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Adverum Biotechnologies, Inc..

Recent SEC filings

FiledFormAccession number
Dec 19, 202515-12G0001193125-25-326766
Dec 11, 2025EFFECT9999999995-25-003651
Dec 11, 2025EFFECT9999999995-25-003652
Dec 11, 2025EFFECT9999999995-25-003650
Dec 10, 202540001814883-25-000005
Dec 10, 202540001736315-25-000006
Dec 10, 202540001574579-25-000004
Dec 10, 202540001311210-25-000004
Dec 10, 202540002026299-25-000004
Dec 10, 202540001775323-25-000004
Dec 10, 202540001321937-25-000005
Dec 10, 202540001356950-25-000004
Dec 10, 202540001915254-25-000005
Dec 10, 202540001511051-25-000005
Dec 10, 202540001903088-25-000005
Dec 10, 202540001298941-25-000005
Dec 10, 202540001379344-25-000006
Dec 10, 202540001636168-25-000003
Dec 9, 202525-NSE0001354457-25-001236
Dec 9, 2025SC 14D9/A0001193125-25-312028
Dec 9, 20258-K0001193125-25-312722
Dec 9, 2025S-8 POS0001193125-25-312864
Dec 9, 2025SC TO-T/A0001193125-25-311997
Dec 9, 2025POS AM0001193125-25-312792
Dec 9, 2025S-8 POS0001193125-25-312800